Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study ; volume:12 ; number:4 ; day:11 ; month:5 ; year:2023 ; pages:1375-1383 ; date:8.2023
Neurology and Therapy ; 12, Heft 4 (11.5.2023), 1375-1383, 8.2023

Creator
Bruschi, Nicolò
Malentacchi, Maria
Malucchi, Simona
Sperli, Francesca
Martire, Serena
Sala, Arianna
Valentino, Paola
Bertolotto, Antonio
Pautasso, Marisa
Capobianco, Marco Alfonso
Contributor
SpringerLink (Online service)

DOI
10.1007/s40120-023-00481-w
URN
urn:nbn:de:101:1-2023092910321858060614
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Bruschi, Nicolò
  • Malentacchi, Maria
  • Malucchi, Simona
  • Sperli, Francesca
  • Martire, Serena
  • Sala, Arianna
  • Valentino, Paola
  • Bertolotto, Antonio
  • Pautasso, Marisa
  • Capobianco, Marco Alfonso
  • SpringerLink (Online service)

Other Objects (12)

Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers

An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression

ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression

Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure

Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure

TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss

TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia

Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia

FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma

FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?

Related objects